NeueHealth (NEUE) vs. Its Competitors Head to Head Analysis

NeueHealth (NYSE:NEUE) is one of 14 public companies in the “Hospital & medical service plans” industry, but how does it contrast to its peers? We will compare NeueHealth to related companies based on the strength of its risk, analyst recommendations, earnings, profitability, valuation, dividends and institutional ownership.

Analyst Ratings

This is a summary of recent ratings for NeueHealth and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0	1	0	0	2.00
NeueHealth Competitors	94	1116	2552	98	2.69

NeueHealth presently has a consensus price target of $8.00, suggesting a potential upside of 35.36%. As a group, “Hospital & medical service plans” companies have a potential upside of 18.89%. Given NeueHealth’s higher probable upside, equities research analysts plainly believe NeueHealth is more favorable than its peers.

Profitability

This table compares NeueHealth and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeueHealth	-71.23%	N/A	-1.21%
NeueHealth Competitors	0.04%	-1.59%	-0.04%

Volatility and Risk

NeueHealth has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, NeueHealth’s peers have a beta of 0.95, suggesting that their average share price is 5% less volatile than the S&P 500.

Valuation and Earnings

This table compares NeueHealth and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NeueHealth	$1.16 billion	-$1.15 billion	-0.04
NeueHealth Competitors	$80.60 billion	$2.78 billion	8.68

NeueHealth’s peers have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

63.9% of NeueHealth shares are owned by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are owned by institutional investors. 64.3% of NeueHealth shares are owned by company insiders. Comparatively, 10.2% of shares of all “Hospital & medical service plans” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

NeueHealth peers beat NeueHealth on 10 of the 13 factors compared.

About NeueHealth

NeueHealth, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, Bright HealthCare and Consumer Care. The Consumer Care segment delivers virtual and in-person clinical care services contracts through primary care clinics. It operates managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers medicare health plan products to consumers. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.